Remember me:
Skip Navigation Links
Axis-Shield resists new Alere takeover attempt

UK-based diagnostics company Axis-Shield has urged shareholders to resist a fresh takeover attempt by US rival Alere.

In a statement today, Alere repeated its offer to Axis-Shield’s shareholders of 460 pence per share, which was formally made on 5 August. The offer, rejected by the Axis-Shield board, values the business at £230 million.

Alere announced today that it is lowering the threshold of its bid, which had been set at 90% of shareholder acceptance. The company said it now required more than 50% of voting rights, giving it the option of becoming a majority shareholder in Axis-Shield.

The US company also warned that if its offer were to lapse by a deadline of 10 October, “there is a strong possibility that Axis-Shield's share price would fall significantly below its current share price, particularly as no other potential bidder has announced its interest publicly”.

Alere said it was also looking at “alternative acquisitions, particularly in light of current valuations and market conditions”, and that it didn’t necessarily have to acquire Axis-Shield in order to achieve its “strategic objectives”.

In response, Axis-Shield’s board said it was “disappointed” that Alere had not taken notice of the “firm rebuttal” from shareholders to its offer, which it said was clear by the less than 1% level of acceptances that was disclosed in an Alere announcement on 16 September.

“The board has been more than willing to engage with Alere if Alere were to put a proposal to the board that fairly reflected the fundamental value of Axis-Shield. To date, no such proposal has been received from Alere,” said an Axis-Shield statement.

“The company has made excellent progress in the first half of the year and is on track to deliver for the second half of the year. The company believes that Alere is making a highly opportunistic offer in order to try and acquire Axis-Shield on the cheap.”

The 460 pence per share offer price represents a premium of 37% on the closing share price of 335 pence on 5 July 2011 – the last business day before Alere revealed it was considering an approach.

Posted on: 26/09/2011

Latest news stories

HCA International has been awarded the Queen’s Award for contribution to international trade, weeks after facing criticism from the UK’s competition regulator.
Private equity house Key Capital Partners has invested £3.3 million into healthcare temporary staffing business Hallam Medical.
Target Healthcare REIT has added two more care homes to its portfolio for a total consideration of £8.9 million.
The Christie NHS Foundation Trust has entered a partnership with Synlab UK to provide pathology services at the cancer specialist trust.
US-based hedge funds DE Shaw and Varde Partners have acquired one of the UK’s largest care businesses, European Care Group (ECG), HealthInvestor can confirm.


A brave new market
The government is about to create a billion pound market in outsourcing commissioning support services. Is it the golden opportunity it appears to be, asks Daniel Thomas Read more...
Dr Victor Chua of Mansfield Advisors believes there is an unmet opportunity for private emergency cardiac care in London
Hedge funds are starting to take an interest in the British healthcare sector. Is this a deal with the devil, or a slug of much-needed investment? Adrian Murdoch investigates
Malling Health teeters between traditional practice and commercialism. So what does it have to offer the sector, asks Thomas Byrne
Getting the executive board right is crucial for a successful business, so what does it take to be a leader in healthcare? Ploy Radford finds out
Dr Victor Chua of Mansfield Advisors believes there is an unmet opportunity for private emergency cardiac care in London
The domiciliary care market is facing a fees crisis. What can providers do, asks Ploy Radford

Click here to search all feature articles